{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:52:13Z","timestamp":1791409933610,"version":"4.3.3"},"reference-count":31,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The escalating use of Glucagon\u2010like peptide\u20101 receptor agonists (GLP\u20101 RAs) is reshaping pharmaceutical consumption patterns and posing unprecedented challenges to healthcare systems worldwide. This study analyzes the landscape of GLP\u20101 RA consumption, safety monitoring and regulatory oversight in Brazil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective regulatory surveillance study was carried out triangulating data from three official sources: (1) national sales covering 2020\u20132024, classifying according to Anatomical Therapeutic Chemical (ATC) system; (2) adverse event reports submitted to Vigimed, the national pharmacovigilance platform integrated with global VigiBase; and (3) official alerts of falsified products. Sales data were sourced from industrial reports and the National System for the Management of Controlled Products (SNGPC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Semaglutide emerged as the predominant GLP\u20101 RA in the Brazilian market. Consumption was markedly concentrated in regions with higher Gross Domestic Product (GDP), revealing a disconnect between medication use and regional diabetes prevalence. Pharmacovigilance analysis uncovered a significant proportion of reports involving off\u2010label use, pointing to potential clinical and regulatory gaps. Furthermore, documented cases of counterfeit products underscore critical supply chain vulnerabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The convergence of escalating demand, widespread off\u2010label use and product falsification requires a coordinated and agile regulatory response. The observed trends suggest significant access disparities driven by economic factors rather than epidemiological need.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.70609","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:21:25Z","timestamp":1773030085000},"page":"4185-4193","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["<scp>GLP<\/scp>\n                    \u20101 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0556-5015","authenticated-orcid":false,"given":"Renato Lopes","family":"Hurtado","sequence":"first","affiliation":[{"name":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa)  Bras\u00edlia Brazil"},{"name":"University of Bras\u00edlia  Bras\u00edlia Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-5504","authenticated-orcid":false,"given":"Ang\u00e9lica Amorim","family":"Amato","sequence":"additional","affiliation":[{"name":"University of Bras\u00edlia  Bras\u00edlia Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"de Luca Corr\u00eaa","sequence":"additional","affiliation":[{"name":"Catholic University of Bras\u00edlia  Bras\u00edlia Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e2maris","family":"Silveira","sequence":"additional","affiliation":[{"name":"University of Bras\u00edlia  Bras\u00edlia Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.34172\/ija.2024.e19"},{"key":"e_1_2_10_3_1","unstructured":"World Health Organization \u201cObesity and Overweight \u201d(2025) https:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/obesity\u2010and\u2010overweight."},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.14092"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.24945"},{"key":"e_1_2_10_6_1","unstructured":"World Health Organization \u201cDiabetes \u201daccessed September 27 2025 https:\/\/www.who.int\/health\u2010topics\/diabetes#tab=tab_1."},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.etdah.2024.100157"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(24)02317\u20101"},{"key":"e_1_2_10_9_1","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE) \u201cEstimativas da Popula\u00e7\u00e3o Residente Nos Munic\u00edpios Brasileiros Com Data de Refer\u00eancia em 1\u00b0 de Julho de 2024 \u201d(Bras\u00edlia DF IBGE: 2024) https:\/\/ftp.ibge.gov.br\/Estimativas_de_Populacao\/Estimativas_2024\/estimativa_dou_2024.pdf."},{"key":"e_1_2_10_10_1","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE) \u201cProduto Interno Bruto Dos Munic\u00edpios 2022 \u201dRio de Janeiro RJ IBGE: 2022) https:\/\/www.ibge.gov.br\/estatisticas\/economicas\/contas\u2010nacionais\/9088\u2010produto\u2010interno\u2010bruto\u2010dos\u2010municipios.html."},{"key":"e_1_2_10_11_1","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria \u201cAnu\u00e1rio Estat\u00edstico do Mercado Farmac\u00eautico 2023 \u201dSecretaria Executiva da C\u00e2mara de Regula\u00e7\u00e3o do Mercado de Medicamentos (2024) https:\/\/www.gov.br\/anvisa\/pt\u2010br\/centraisdeconteudo\/publicacoes\/medicamentos\/cmed\/anuario\u2010estatistico\u2010do\u2010mercado\u2010farmaceutico\u20102023.pdf."},{"key":"e_1_2_10_12_1","unstructured":"Minist\u00e9rio da Sa\u00fade (Brasil) \u201cVigitel \u201dMinist\u00e9rio da Sa\u00fade (2025) https:\/\/www.gov.br\/saude\/pt\u2010br\/composicao\/svsa\/inqueritos\u2010de\u2010saude\/vigitel."},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2032183"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2206038"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300\u2010021\u201001053\u20107"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15828"},{"key":"e_1_2_10_17_1","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Brasil) \u201cVoto n\u00b0 92\/2024\u2014Processo SEI n\u00b0 25351.822421\/2024\u201311 \u201d(Bras\u00edlia Anvisa: 2024) https:\/\/www.gov.br\/anvisa\/pt\u2010br\/composicao\/diretoria\u2010colegiada\/reunioes\u2010da\u2010diretoria\/votos\u2010dos\u2010circuitos\u2010deliberativos\u20101\/2024\/cd\u2010383\u20102024\u2010voto.pdf."},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2024.2322049"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2024.2444642"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.52582"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.36557\/2674\u20108169.2025v7n4p985\u20101000"},{"key":"e_1_2_10_22_1","first-page":"87","volume-title":"Ci\u00eancias da Sa\u00fade: Abordagens Interdisciplinares e Inova\u00e7\u00f5es Cient\u00edficas","author":"Ara\u00fajo M.","year":"2025"},{"key":"e_1_2_10_23_1","unstructured":"A. M.Ivama\u2010Brummell F.Alves andF.Cruz \u201cOff\u2010Label Use of Glucagon\u2010Like Peptide 1 (GLP\u20101) Drugs in Brazil and Possible Regulatory Implications: Preliminary Results \u201dIn:Abstract Book of the European Drug Utilization Conference 2025 (Uppsala Uppsala University: 2025) 309\u2013310."},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41366\u2010025\u201001859\u20106"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1613610"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19574"},{"key":"e_1_2_10_27_1","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Brasil) \u201cAlerta Sobre Risco do Uso de Agonistas GLP\u20101 em Pacientes Submetidos a Anestesia ou Seda\u00e7\u00e3o Profunda \u201d(Bras\u00edlia Anvisa: 2024) https:\/\/www.gov.br\/anvisa\/pt\u2010br\/assuntos\/noticias\u2010anvisa\/2024\/anvisa\u2010alerta\u2010sobre\u2010o\u2010risco\u2010do\u2010uso\u2010de\u2010medicamentos\u2010agonistas\u2010glp\u20101\u2010em\u2010pacientes\u2010que\u2010serao\u2010submetidos\u2010a\u2010anestesia\u2010ou\u2010sedacao\u2010profunda."},{"key":"e_1_2_10_28_1","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Brasil) \u201cResolu\u00e7\u00e3o RDC n\u00b0 973 de 23 de Abril de 2025 \u201dDi\u00e1rio Oficial da Uni\u00e3o (2025) https:\/\/www.legisweb.com.br\/legislacao\/?id=477177."},{"key":"e_1_2_10_29_1","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Brasil) \u201cInstru\u00e7\u00e3o Normativa n\u00b0 360 de 23 de Abril de 2025.Di\u00e1rio Oficial da Uni\u00e3o \u201d(2025) https:\/\/www.in.gov.br\/web\/dou\/\u2010\/instrucao\u2010normativa\u2010in\u2010n\u2010360\u2010de\u201023\u2010de\u2010abril\u2010de\u20102025\u2010625476355."},{"key":"e_1_2_10_30_1","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Brasil) \u201cDespacho n\u00b0 97 de 22 de Agosto de 2025 \u201dDi\u00e1rio Oficial da Uni\u00e3o (2025) https:\/\/www.editoraroncarati.com.br\/v2\/phocadownload\/anexos\/25082025_anvisa.pdf."},{"key":"e_1_2_10_31_1","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) \u201cListas de Pre\u00e7os de Medicamentos (CMED): Pre\u00e7o M\u00e1ximo ao Consumidor (PMC) \u201daccessed September 27 2025 Portal Gov.br https:\/\/www.gov.br\/anvisa\/pt\u2010br\/assuntos\/medicamentos\/cmed\/precos."},{"key":"e_1_2_10_32_1","unstructured":"Minist\u00e9rio da Sa\u00fade (Brasil). Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade Ata da 25\u00aa Reuni\u00e3o Extraordin\u00e1ria da ConitecBras\u00edlia DF Minist\u00e9rio da Sa\u00fade (2025) https:\/\/www.gov.br\/conitec\/pt\u2010br\/midias\/reuniao_conitec\/2025\/ata\u2010da\u201025a\u2010reuniao\u2010extraordinaria\u2010da\u2010conitec_comite\u2010de\u2010medicamentos."}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.70609","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.70609","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.70609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:37Z","timestamp":1787026957000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/10.1111\/dom.70609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1111\/dom.70609"],"URL":"https:\/\/doi.org\/10.1111\/dom.70609","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.70609\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70609\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70609\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70609\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70609\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70609\/v1\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70609\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]},"assertion":[{"value":"2026-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}